FDA Advisers Vote to Replace Original COVID Vaccine With Bivalent Boosters Despite Lack of Clinical Trial Data
Bill Gates — After Reaping Huge Profits Selling BioNTech Shares — Trashes Effectiveness of COVID Vaccines